IS5740A - Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess - Google Patents

Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess

Info

Publication number
IS5740A
IS5740A IS5740A IS5740A IS5740A IS 5740 A IS5740 A IS 5740A IS 5740 A IS5740 A IS 5740A IS 5740 A IS5740 A IS 5740A IS 5740 A IS5740 A IS 5740A
Authority
IS
Iceland
Prior art keywords
glutathione
carnitine
synergistic effect
composition consisting
absorption
Prior art date
Application number
IS5740A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of IS5740A publication Critical patent/IS5740A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5740A 1999-04-16 2000-11-28 Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess IS5740A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000230A IT1306130B1 (it) 1999-04-16 1999-04-16 Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
PCT/IT2000/000129 WO2000062773A1 (en) 1999-04-16 2000-04-07 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects

Publications (1)

Publication Number Publication Date
IS5740A true IS5740A (is) 2000-11-28

Family

ID=11406677

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5740A IS5740A (is) 1999-04-16 2000-11-28 Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess

Country Status (25)

Country Link
US (1) US6306392B1 (is)
EP (1) EP1087762B1 (is)
JP (1) JP2002542191A (is)
KR (1) KR20010071467A (is)
CN (1) CN1300214A (is)
AR (1) AR033325A1 (is)
AT (1) ATE282409T1 (is)
AU (1) AU774191B2 (is)
BR (1) BR0006045A (is)
CA (1) CA2334919C (is)
DE (1) DE60015893T2 (is)
EE (1) EE200000732A (is)
ES (1) ES2232443T3 (is)
HU (1) HU229272B1 (is)
IL (1) IL139851A0 (is)
IS (1) IS5740A (is)
IT (1) IT1306130B1 (is)
NO (1) NO20006285L (is)
NZ (1) NZ509276A (is)
PL (1) PL213130B1 (is)
PT (1) PT1087762E (is)
SK (1) SK18852000A3 (is)
TN (1) TNSN00077A1 (is)
TR (1) TR200003688T1 (is)
WO (1) WO2000062773A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306147B1 (it) * 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
KR100528720B1 (ko) * 2002-08-29 2005-11-15 주식회사 메디넥스 중금속 제거용 특수 영양식품
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
DK1817058T3 (en) * 2004-11-24 2015-12-07 Hills Pet Nutrition Inc COMPOSITION FOR USE FOR IMPROVING THE hepatic clearance xenobiotics WITH AN ANIMAL
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5295567B2 (ja) 2004-12-30 2013-09-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 高齢期の動物の生活の質を高めるための方法
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
RU2377980C2 (ru) * 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
JP4831540B2 (ja) * 2005-08-26 2011-12-07 株式会社興人 経口催眠剤及び催眠性飲食物
JP2009107962A (ja) * 2007-10-29 2009-05-21 Asahi Breweries Ltd 酵母エキス含有組成物
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
CN103478718B (zh) * 2013-09-27 2015-10-28 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的功能食品及其制备方法
CN103535721B (zh) * 2013-09-27 2016-04-06 美国东方生物技术（香港）有限公司 提高人体内谷胱甘肽浓度的组合物及其制备方法和应用
CN103750344B (zh) * 2014-01-25 2015-11-04 北京凯因科技股份有限公司 一种酵母谷胱甘肽营养配制品
IL261670B (en) * 2018-09-06 2019-06-30 Tudu Holdings Ltd A preparation that includes magnesium and its uses
JP7478517B2 (ja) * 2019-04-24 2024-05-07 三菱商事ライフサイエンス株式会社 脂質活性代謝改善組成物
KR102559814B1 (ko) * 2021-05-14 2023-07-26 가톨릭대학교 산학협력단 글루타치온을 유효성분으로 포함하는 신장질환 치료용 약학적 조성물
KR102535328B1 (ko) * 2022-10-18 2023-05-26 주식회사 청안오가닉스 흑후추 추출물을 함유하여 글루타치온의 체내 흡수율을 높인 건강기능 식품용 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
HU229272B1 (en) 2013-10-28
JP2002542191A (ja) 2002-12-10
HUP0102501A2 (hu) 2001-11-28
DE60015893D1 (de) 2004-12-23
IL139851A0 (en) 2002-02-10
EE200000732A (et) 2002-06-17
NO20006285L (no) 2001-02-12
DE60015893T2 (de) 2005-12-01
KR20010071467A (ko) 2001-07-28
SK18852000A3 (sk) 2001-06-11
ITRM990230A1 (it) 2000-10-16
NZ509276A (en) 2002-09-27
ATE282409T1 (de) 2004-12-15
EP1087762A1 (en) 2001-04-04
TNSN00077A1 (fr) 2002-05-30
NO20006285D0 (no) 2000-12-11
IT1306130B1 (it) 2001-05-30
EP1087762B1 (en) 2004-11-17
TR200003688T1 (tr) 2001-06-21
US6306392B1 (en) 2001-10-23
CA2334919C (en) 2009-02-24
AU774191B2 (en) 2004-06-17
PL344790A1 (en) 2001-11-19
HUP0102501A3 (en) 2002-12-28
AR033325A1 (es) 2003-12-17
CN1300214A (zh) 2001-06-20
PT1087762E (pt) 2005-03-31
BR0006045A (pt) 2001-03-13
ES2232443T3 (es) 2005-06-01
PL213130B1 (pl) 2013-01-31
AU4311700A (en) 2000-11-02
WO2000062773A1 (en) 2000-10-26
CA2334919A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
IS5740A (is) Samsetning sem samanstendur af karnitíni, glútaþíóni (glutathione) gagnlegu til að auka gleypni glútaþíóns og samverka áhrif þess
IS5850A (is) Andoxunar samsetning sem samanstendur af asetýl L-karnitíni og alfa-lípósýru
EP1558321A4 (en) MASK AND ASSOCIATED COMPONENTS
AU2003291726A8 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
AU2003262747A8 (en) Compounds, compositions, and methods
EP1503993A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS
EP1513820A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
DE10197047T1 (de) Unverlierbare Schraube
AU2003288133A8 (en) Herbidical composition
AU2003224454A8 (en) Thiol compound, photopolymerization initiator composition and photosensitive composition
IL164581A0 (en) Compounds, compositions and methods
EP1559433A4 (en) STABILIZED COMPOSITION
IL166331A0 (en) 5-arylterazole compounds compositions thereof and uses therefor
DE60016836D1 (de) Resistzusammensetzung
NO20013853L (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
IS5816A (is) Andoxunarefni, andfjölgunarsamsetning, sem samanstendur af karnitíni og karótínóíði
EP1395280A4 (en) COMPOSITION AND METHOD OF INFLUENCING METALOCORRINOIDE RECEPTION
ATE341948T1 (de) Zusammensetzung enthaltend kreatin und kreatinin
DE60216645D1 (de) Antiulcus pflanzenzusammensetzung(en)
AU2003267169A8 (en) Compounds, compositions and methods
EP1558589A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
DK1087762T3 (da) Præparat omfattende et carnitin og glutathion, som er egnet til at öge absorptionen af glutathion og göre dets virkninger synergistiske
FR2831088B3 (fr) Tournevis perfectionne
NO20011859L (no) Imidazoisokinolinforbindelser, deres sammensetninger og anvendelse
ES1052666Y (es) Tornillo de apriete perfeccionado.